Learn more about medical terms and key words related to EYLEA and Macular Edema following Retinal Vein Occlusion (MEfRVO).
A simple vision test that looks like graph paper with a dot in the middle. May be used at home as a tool to monitor vision between eye care appointments.
A treatment for MEfRVO designed to block VEGF (a protein made by the blood vessels that, at high levels, can cause abnormal blood vessels to grow in the eye and leak fluid).
Hardening of the arteries.
An eye disease in which a blood clot blocks one or more veins branching out from the central retinal vein (the main vein that drains blood away from the retina), causing fluid to leak into the retina.
An eye disease in which a blood clot blocks the central retinal vein (the main vein that drains blood away from the retina), causing fluid to leak into the retina.
An exam for checking the back of the eye, including the retina, for signs of problems or changes. To see into the back of the eye, the doctor puts drops into the eye to dilate (widen) the pupil.
A chart for measuring visual acuity (how well a person sees) that has rows of letters that get smaller from top to bottom. A person reads the smallest letters seen. The more letters seen, the better the vision.
A test in which dye is used to show the blood vessels in the back of the eye.
A test in which a special camera takes photos showing the inside of the back of the eye.
High pressure in the eye.
A doctor trained to give low vision examinations and prescribe low vision devices and services.
The part of the retina responsible for sharp central vision.
The light-sensitive tissue at the back of the eye.
A protein made by the blood vessels that, at high levels, can cause abnormal blood vessels to grow in the eye and leak fluid.
Measures how well you see the letters on an eye chart from a distance.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
EYLEA® (aflibercept) Injection is a prescription medicine approved for the treatment of patients with:
The information contained herein is provided for general educational purposes. If you have any questions, talk to your doctor.